BDNF gene polymorphisms and substance use disorders: a systematic review

References

Agrawal, A., Lynskey, M.T., Kapoor, M., Bucholz, K.K., Edenberg, H.J., Schuckit, M., Brooks, A., Hesselbrock, V., Kramer, J., Saccone, N., et al. (2015). Are genetic variants for tobacco smoking associated with cannabis involvement? Drug Alcohol Depend. 150: 183–187, https://doi.org/10.1016/j.drugalcdep.2015.02.029.Search in Google Scholar PubMed PubMed Central

Al-Eitan, L.N., Jaradat, S.A., Hulse, G.K., and Tay, G.K. (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497, https://doi.org/10.1186/1756-0500-5-497.Search in Google Scholar PubMed PubMed Central

Anmella, G., Vilches, S., Espadaler-Mazo, J., Murru, A., Pacchiarotti, I., Tuson, M., Garriga, M., Solé, E., Brat, M., Fico, G., et al. (2021). Genetic variations associated with long-term treatment response in bipolar depression. Genes (Basel) 12: 1259, https://doi.org/10.3390/genes12081259.Search in Google Scholar PubMed PubMed Central

Autry, A.E. and Monteggia, L.M. (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64: 238–258, https://doi.org/10.1124/pr.111.005108.Search in Google Scholar PubMed PubMed Central

Baj, G., Carlino, D., Gardossi, L., and Tongiorgi, E. (2013). Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. Front. Neurosci. 7: 188, https://doi.org/10.3389/fnins.2013.00188.Search in Google Scholar PubMed PubMed Central

Bardeen, J.R., Daniel, T.A., Gratz, K.L., Vallender, E.J., Garrett, M.R., and Tull, M.T. (2020). The BDNF Val66Met polymorphism moderates the relationship between posttraumatic stress disorder and trauma script-evoked attentional bias to cocaine cues among patients with cocaine dependence. J. Anxiety Disord. 72: 102223, https://doi.org/10.1016/j.janxdis.2020.102223.Search in Google Scholar PubMed PubMed Central

Batalla, A., Lorenzetti, V., Chye, Y., Yücel, M., Soriano-Mas, C., Bhattacharyya, S., Torrens, M., Crippa, J.A.S., and Martín-Santos, R. (2018). The influence of DAT1, COMT, and BDNF genetic polymorphisms on total and subregional hippocampal volumes in early onset heavy cannabis users. Cannabis Cannabinoid Res. 3: 1–10, https://doi.org/10.1089/can.2017.0021.Search in Google Scholar PubMed PubMed Central

Bawor, M., Dennis, B.B., Tan, C., Pare, G., Varenbut, M., Daiter, J., Plater, C., Worster, A., Marsh, D.C., Steiner, M., et al. (2015). Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addict. Sci. Clin. Pract. 10: 19, https://doi.org/10.1186/s13722-015-0040-7.Search in Google Scholar PubMed PubMed Central

Berent, D., Szymańska, B., Kulczycka-Wojdala, D., Macander, M., Pawłowska, Z., and Wojnar, M. (2020). The role of childhood adversities, FKBP5, BDNF, NRN1, and generalized self-efficacy in suicide attempts in alcohol-dependent patients. Pharmacol. Rep. 72: 730–743, https://doi.org/10.1007/s43440-020-00080-8.Search in Google Scholar PubMed PubMed Central

Beuten, J., Ma, J.Z., Payne, T.J., Dupont, R.T., Quezada, P., Huang, W., Crews, K.M., and Li, M.D. (2005). Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B: 73–80, https://doi.org/10.1002/ajmg.b.30231.Search in Google Scholar PubMed

Biskupska, J., Borowiak, K.S., Karlin-Grazewicz, K., Janus, T., Waloszczyk, P., Potocka-Banas, B., Machoy-Mokrzynska, A., Ossowski, A., and Ciechanowicz, A. (2013). Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates. Hum. Exp. Toxicol. 32: 236–240, https://doi.org/10.1177/0960327112459203.Search in Google Scholar PubMed

Boroń, A., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Masiak, J., Trybek, G., Strońska-Pluta, A., Rychel, M., and Grzywacz, A. (2024). Analysis of the BDNF gene rs6265 polymorphism in a group of women with alcohol use disorder, taking into account personality traits. Int. J. Mol. Sci. 25: 6448, https://doi.org/10.3390/ijms25126448.Search in Google Scholar PubMed PubMed Central

Bousman, C.A. and Dunlop, B.W. (2018). Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools. Pharmacogenomics J. 18: 613–622, https://doi.org/10.1038/s41397-018-0027-3.Search in Google Scholar PubMed

Bousman, C.A., Glatt, S.J., Cherner, M., Atkinson, J.H., Grant, I., Tsuang, M.T., Everall, I.P., and HNRC, Group. (2010). Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 178: 295–298, https://doi.org/10.1016/j.psychres.2009.07.019.Search in Google Scholar PubMed PubMed Central

Caffino, L., Mottarlini, F., Bilel, S., Targa, G., Tirri, M., Maggi, C., Marti, M., and Fumagalli, F. (2021). Single exposure to the cathinones MDPV and α-PVP alters molecular markers of neuroplasticity in the adult mouse brain. Int. J. Mol. Sci. 22: 7397, https://doi.org/10.3390/ijms22147397.Search in Google Scholar PubMed PubMed Central

Carver, C.S., LeMoult, J., Johnson, S.L., and Joormann, J. (2014). Gene effects and G × E interactions in the differential prediction of three aspects of impulsiveness. Soc. Psychol. Personal. Sci. 5: 730–739, https://doi.org/10.1177/1948550614527116.Search in Google Scholar

Castillo-Carniglia, A., Keyes, K.M., Hasin, D.S., and Cerdá, M. (2019). Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry 6: 1068–1080, https://doi.org/10.1016/s2215-0366(19)30222-6.Search in Google Scholar

Cheah, S.Y., Lawford, B.R., Young, R.M., Connor, J.P., Phillip Morris, C., and Voisey, J. (2014). BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia. Alcohol Alcohol 49: 491–497, https://doi.org/10.1093/alcalc/agu040.Search in Google Scholar PubMed

Chen, S.L., Lee, S.Y., Chang, Y.H., Wang, T.Y., Chen, S.H., Chu, C.H., Chen, P.S., Yang, Y.K., Hong, J.S., and Lu, R.B. (2015). The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients. Sci. Rep. 5: 8148, https://doi.org/10.1038/srep08148.Search in Google Scholar PubMed PubMed Central

Chen, S., Zhou, W., and Lai, M. (2024). Synthetic cathinones: epidemiology, toxicity, potential for abuse, and current public health perspective. Brain Sci. 14: 334, https://doi.org/10.3390/brainsci14040334.Search in Google Scholar PubMed PubMed Central

Cheng, C.Y., Hong, C.J., Yu, Y.W., Chen, T.J., Wu, H.C., and Tsai, S.J. (2005). Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res. Mol. Brain Res. 140: 86–90, https://doi.org/10.1016/j.molbrainres.2005.07.008.Search in Google Scholar PubMed

Crist, R.C., Reiner, B.C., and Berrettini, W.H. (2019). A review of opioid addiction genetics. Curr. Opin. Psychol. 27: 31–35, https://doi.org/10.1016/j.copsyc.2018.07.014.Search in Google Scholar PubMed PubMed Central

Cuyàs, E., Verdejo-García, A., Fagundo, A.B., Khymenets, O., Rodríguez, J., Cuenca, A., de Sola Llopis, S., Langohr, K., Peña-Casanova, J., Torrens, M., et al. (2011). The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS One 6: e27206, https://doi.org/10.1371/journal.pone.0027206.Search in Google Scholar PubMed PubMed Central

Dalvie, S., Stein, D.J., Koenen, K., Cardenas, V., Cuzen, N.L., Ramesar, R., Fein, G., and Brooks, S.J. (2014). The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14: 328, https://doi.org/10.1186/s12888-014-0328-2.Search in Google Scholar PubMed PubMed Central

de Cid, R., Fonseca, F., Gratacòs, M., Gutierrez, F., Martín-Santos, R., Estivill, X., and Torrens, M. (2008). BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Gene Brain Behav. 7: 515–522, https://doi.org/10.1111/j.1601-183X.2007.00386.x.Search in Google Scholar PubMed

Deak, J.D. and Johnson, E.C. (2021). Genetics of substance use disorders: a review. Psychol. Med. 51: 2189–2200, https://doi.org/10.1017/s0033291721000969.Search in Google Scholar

Decoster, J., van Os, J., Kenis, G., Henquet, C., Peuskens, J., De Hert, M., and van Winkel, R. (2011). Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B: 363–369, https://doi.org/10.1002/ajmg.b.31174.Search in Google Scholar PubMed

Devlin, P., Cao, X., and Stanfill, A.G. (2021). Genotype-expression interactions for BDNF across human brain regions. BMC Genomics 22: 207, https://doi.org/10.1186/s12864-021-07525-1.Search in Google Scholar PubMed PubMed Central

Duart-Castells, L., López-Arnau, R., Vizcaíno, S., Camarasa, J., Pubill, D., and Escubedo, E. (2019). 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: differential role of the BDNF-TrkB pathway. Biochem. Pharmacol. 163: 84–93, https://doi.org/10.1016/j.bcp.2019.02.004.Search in Google Scholar PubMed

Durazzo, T.C., Hutchison, K.E., Fryer, S.L., Mon, A., and Meyerhoff, D.J. (2012). Associations of cigarette smoking and polymorphisms in brain-derived neurotrophic factor and Catechol-O-Methyltransferase with neurocognition in alcohol dependent individuals during early abstinence. Front. Pharmacol. 3: 178, https://doi.org/10.3389/fphar.2012.00178.Search in Google Scholar PubMed PubMed Central

Durazzo, T.C., McNerney, M.W., Hansen, A.M., Gu, M., Sacchet, M.D., and Padula, C.B. (2023). BDNF rs6265 Met carriers with alcohol use disorder show greater age-related decline of N-acetylaspartate in left dorsolateral prefrontal cortex. Drug Alcohol Depend. 248: 109901, https://doi.org/10.1016/j.drugalcdep.2023.109901.Search in Google Scholar PubMed

Espadaler, J., Tuson, M., Lopez-Ibor, J.M., Lopez-Ibor, F., and Lopez-Ibor, M.I. (2017). Pharmacogenetic testing for the guidance of psychiatric treatment: a multicenter retrospective analysis. CNS Spectr. 22: 315–324, https://doi.org/10.1017/s1092852915000711.Search in Google Scholar PubMed

Evangelia, L., Ilias, K., Leonidas, M., Elias, T., and Maria, G. (2024). Deciphering the role of genetics in alcohol use disorder. In: Martin, C.R., Preedy, V.R., Patel, V.B., and Rajendram, R. (Eds.). Handbook of the biology and pathology of mental disorders. Springer, Cham, pp. 1–34.10.1007/978-3-031-32035-4_119-1Search in Google Scholar

Evangelou, E., Gao, H., Chu, C., Ntritsos, G., Blakeley, P., Butts, A.R., Pazoki, R., Suzuki, H., Koskeridis, F., Yiorkas, A.M., et al. (2019). New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders. Nat. Hum. Behav. 3: 950–961, https://doi.org/10.1038/s41562-019-0653-z.Search in Google Scholar PubMed PubMed Central

Fan, Y., Luan, X., Wang, X., Li, H., Zhao, H., Li, S., Li, X., and Qiu, Z. (2025). Exploring the association between BDNF related signaling pathways and depression: a literature review. Brain Res. Bull. 220: 111143, https://doi.org/10.1016/j.brainresbull.2024.111143.Search in Google Scholar PubMed

Feltenstein, M.W. and See, R.E. (2013). Systems level neuroplasticity in drug addiction. Cold Spring. Harb. Perspect. Med. 3: a011916, https://doi.org/10.1101/cshperspect.a011916.Search in Google Scholar PubMed PubMed Central

Forero, D.A., López-León, S., Shin, H.D., Park, B.L., and Kim, D.J. (2015). Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence. Drug Alcohol Depend 149: 259–263, https://doi.org/10.1016/j.drugalcdep.2015.01.017.Search in Google Scholar PubMed

Gao, X., Wang, Y., Lang, M., Yuan, L., Reece, A.S., and Wang, W. (2017). Contribution of genetic polymorphisms and haplotypes in DRD2, BDNF, and opioid receptors to heroin dependence and endophenotypes among the Han Chinese. OMICS 21: 404–412, https://doi.org/10.1089/omi.2017.0057.Search in Google Scholar PubMed

Gelernter, J. and Polimanti, R. (2021). Genetics of substance use disorders in the era of big data. Nat. Rev. Genet. 22: 712–729, https://doi.org/10.1038/s41576-021-00377-1.Search in Google Scholar PubMed PubMed Central

Gerring, Z.F., Thorp, J.G., Treur, J.L., Verweij, K.J.H., and Derks, E.M. (2024). The genetic landscape of substance use disorders. Mol. Psychiatr. 29: 3694–3705, https://doi.org/10.1038/s41380-024-02547-z.Search in Google Scholar PubMed PubMed Central

Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., Pickering, R.P., and Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61: 807–816, https://doi.org/10.1001/archpsyc.61.8.807.Search in Google Scholar PubMed

Gratacòs, M., González, J.R., Mercader, J.M., de Cid, R., Urretavizcaya, M., and Estivill, X. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61: 911–922, https://doi.org/10.1016/j.biopsych.2006.08.025.Search in Google Scholar PubMed

Greenwald, M.K., Steinmiller, C.L., Sliwerska, E., Lundahl, L., and Burmeister, M. (2013). BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict. Biol. 18: 836–845, https://doi.org/10.1111/j.1369-1600.2011.00431.x.Search in Google Scholar PubMed PubMed Central

Grzywacz, A., Samochowiec, A., Ciechanowicz, A., and Samochowiec, J. (2010). Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol. Rep. 62: 938–941, https://doi.org/10.1016/s1734-1140(10)70354-6.Search in Google Scholar PubMed

Guerin, A.A., Nestler, E.J., Berk, M., Lawrence, A.J., Rossell, S.L., and Kim, J.H. (2021). Genetics of methamphetamine use disorder: a systematic review and meta-analyses of gene association studies. Neurosci. Biobehav. Rev. 120: 48–74, https://doi.org/10.1016/j.neubiorev.2020.11.001.Search in Google Scholar PubMed PubMed Central

Guerin, A.A., Spolding, B., Bozaoglu, K., Swinton, C., Liu, Z., Panizzutti Parry, B., Truong, T., Dean, B., Lawrence, A.J., Bonomo, Y., et al. (2024). Associations between methamphetamine use disorder and SLC18A1, SLC18A2, BDNF, and FAAH gene sequence variants and expression levels. Dialogues Clin. Neurosci. 26: 64–76, https://doi.org/10.1080/19585969.2024.2413476.Search in Google Scholar PubMed PubMed Central

Haerian, B.S. (2013). BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis. Pharmacogenomics 14: 2055–2065, https://doi.org/10.2217/pgs.13.217.Search in Google Scholar PubMed

Hall, F.S., Drgonova, J., Jain, S., and Uhl, G.R. (2013). Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? Pharmacol. Ther. 140: 267–279, https://doi.org/10.1016/j.pharmthera.2013.07.006.Search in Google Scholar PubMed PubMed Central

Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F., and Weinberger, D.R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23: 6690–6694, https://doi.org/10.1523/jneurosci.23-17-06690.2003.Search in Google Scholar PubMed PubMed Central

Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H.J., Lang, U.E., Fusar-Poli, P., and Borgwardt, S. (2015). BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 55: 107–118, https://doi.org/10.1016/j.neubiorev.2015.04.017.Search in Google Scholar PubMed

Hatoum, A.S., Colbert, S.M.C., Johnson, E.C., Huggett, S.B., Deak, J.D., Pathak, G., Jennings, M.V., Paul, S.E., Karcher, N.R., Hansen, I., et al. (2023). Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders. Nat. Ment. Health 1: 210–223, https://doi.org/10.1038/s44220-023-00034-y.Search in Google Scholar PubMed PubMed Central

He, L., Liao, Y., Wu, Q., and Liu, T. (2020). Association between brain-derived neurotrophic factor Val66Met polymorphism and methamphetamine use disorder: a meta-analysis. Front. Psychiatry 11: 585852, https://doi.org/10.3389/fpsyt.2020.585852.Search in Google Scholar PubMed PubMed Central

Heinzerling, K.G., McCracken, J.T., Swanson, A.N., Ray, L.A., and Shoptaw, S.J. (2012). COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J. Clin. Psychopharmacol. 32: 135–137, https://doi.org/10.1097/jcp.0b013e318240a48e.Search in Google Scholar PubMed PubMed Central

Heinzerling, K.G. and Shoptaw, S. (2012). Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use. Gend. Med. 9: 112–120, https://doi.org/10.1016/j.genm.2012.02.005.Search in Google Scholar PubMed PubMed Central

Hoefer, M.E., Pennington, D.L., Durazzo, T.C., Mon, A., Abé, C., Truran, D., Hutchison, K.E., and Meyerhoff, D.J. (2014). Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol 48: 631–638, https://doi.org/10.1016/j.alcohol.2014.08.007.Search in Google Scholar PubMed PubMed Central

Hou, H., Qing, Z., Jia, S., Zhang, X., Hu, S., and Hu, J. (2010). Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res. 1353: 245–248, https://doi.org/10.1016/j.brainres.2010.07.022.Search in Google Scholar PubMed

Iamjan, S.A., Thanoi, S., Watiktinkorn, P., Nudmamud-Thanoi, S., and Reynolds, G.P. (2015). BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. Pharmacogenomics 16: 1541–1545, https://doi.org/10.2217/pgs.15.96.Search in Google Scholar PubMed

Itoh, K., Hashimoto, K., Shimizu, E., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Iwata, N., Komiyama, T., Yamada, M., et al. (2005). Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132B: 70–73, https://doi.org/10.1002/ajmg.b.30097.Search in Google Scholar PubMed

Jamal, M., Van der Does, W., and Penninx, B.W. (2015). Effect of variation in BDNF Val(66)Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders. Drug Alcohol Depend 148: 150–157, https://doi.org/10.1016/j.drugalcdep.2014.12.032.Search in Google Scholar PubMed

Jenwitheesuk, A., Pabalan, N., Tapanadechopone, P., Jarjanazi, H., Arunphalungsanti, K., and Tharabenjasin, P. (2025). Association of brain-derived neurotrophic factor polymorphisms with alcohol use disorder: an updated meta-analysis of genetic association studies. Brain Behav. 15: e70359, https://doi.org/10.1002/brb3.70359.Search in Google Scholar PubMed PubMed Central

Jia, W., Shi, J.G., Wu, B., Ao, L., Zhang, R., and Zhu, Y.S. (2011). Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci. Lett. 495: 221–224, https://doi.org/10.1016/j.neulet.2011.03.072.Search in Google Scholar PubMed

Jin, T., Zhang, H., Yang, Q., Li, L., Ouyang, Y., Yang, M., Wang, F., Wang, Z., Zhang, J., and Yuan, D. (2016). The relationship between polymorphisms of BDNFOS and BDNF genes and heroin addiction in the Han Chinese population. J. Gene Med. 18: 288–293, https://doi.org/10.1002/jgm.2927.Search in Google Scholar PubMed

Jones, S.C., Cardone, K.M., Bradford, Y., Tishkoff, S.A., and Ritchie, M.D. (2025). The impact of ancestry on genome-wide association studies. Pac. Symp. Biocomput. 30: 251–267, https://doi.org/10.1142/9789819807024_0019.Search in Google Scholar PubMed PubMed Central

Kalivas, P.W. and O’Brien, C. (2008). Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33: 166–180, https://doi.org/10.1038/sj.npp.1301564.Search in Google Scholar PubMed

Karlsson Linnér, R., Biroli, P., Kong, E., Meddens, S.F.W., Wedow, R., Fontana, M.A., Lebreton, M., Tino, S.P., Abdellaoui, A., Hammerschlag, A.R., et al. (2019). Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat. Genet. 51: 245–257, https://doi.org/10.1038/s41588-018-0309-3.Search in Google Scholar PubMed PubMed Central

Kaya-Akyüzlü, D., Özkan-Kotiloğlu, S., Bal, C., Avcıoğlu, G., Yalçın-Şahiner, Ş., and Şahiner, İ.V. (2022). Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder. Environ. Toxicol. Pharmacol. 95: 103979, https://doi.org/10.1016/j.etap.2022.103979.Search in Google Scholar PubMed

Kilpatrick, D.G., Resnick, H.S., Milanak, M.E., Miller, M.W., Keyes, K.M., and Friedman, M.J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J. Trauma Stress. 26: 537–547, https://doi.org/10.1002/jts.21848.Search in Google Scholar PubMed PubMed Central

Klimkiewicz, A., Mach, A., Jakubczyk, A., Klimkiewicz, J., Wnorowska, A., Kopera, M., Fudalej, S., Burmeister, M., Brower, K., and Wojnar, M. (2017). COMT and BDNF gene variants help to predict alcohol consumption in alcohol-dependent patients. J. Addict. Med. 11: 114–118, https://doi.org/10.1097/adm.0000000000000277.Search in Google Scholar

Koskela, M., Bäck, S., Võikar, V., Richie, C.T., Domanskyi, A., Harvey, B.K., and Airavaara, M. (2017). Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol. Dis. 97: 189–200, https://doi.org/10.1016/j.nbd.2016.05.010.Search in Google Scholar PubMed PubMed Central

Kourosh-Arami, M., Komaki, A., and Gholami, M. (2022). Addiction-induced plasticity in underlying neural circuits. Neurol. Sci. 43: 1605–1615, https://doi.org/10.1007/s10072-021-05778-y.Search in Google Scholar PubMed

Lacroix, A., Ramoz, N., Girard, M., Plansont, B., Poupon, D., Gorwood, P., and Nubukpo, P. (2023). BDNF CpG methylation and serum levels covary during alcohol withdrawal in patients with alcohol use disorder: a pilot study. World J. Biol. Psychiatry 24: 854–859, https://doi.org/10.1080/15622975.2023.2242924.Search in Google Scholar PubMed

Levchenko, A., Malov, S., Antonik, A., Protsvetkina, A., Rybakova, K.V., Kanapin, A., Yakovlev, A.N., Nenasteva, A.Y., Nikolishin, A.E., Cherkasov, N., et al. (2022). A genome-wide association study reveals a BDNF-centered molecular network associated with alcohol dependence and related clinical measures. Biomedicines 10: 3007, https://doi.org/10.3390/biomedicines10123007.Search in Google Scholar PubMed PubMed Central

Levran, O., Peles, E., Randesi, M., Shu, X., Ott, J., Shen, P.H., Adelson, M., and Kreek, M.J. (2013). Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14: 755–768, https://doi.org/10.2217/pgs.13.58.Search in Google Scholar PubMed PubMed Central

Li, M.D., Ma, J.Z., Cheng, R., Dupont, R.T., Williams, N.J., Crews, K.M., Payne, T.J., Elston, R.C., and Study, Framingham Heart (2003). A genome-wide scan to identify loci for smoking rate in the Framingham heart study population. BMC Genet. 4: S103, https://doi.org/10.1186/1471-2156-4-s1-s103.Search in Google Scholar PubMed PubMed Central

Li, S., Weinstein, G., Zare, H., Teumer, A., Völker, U., Friedrich, N., Knol, M.J., Satizabal, C.L., Petyuk, V.A., Adams, H.H.H., et al. (2020). The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages. Brain Commun. 2: fcaa176, https://doi.org/10.1093/braincomms/fcaa176.Search in Google Scholar PubMed PubMed Central

Liu, M., Jiang, Y., Wedow, R., Li, Y., Brazel, D.M., Chen, F., Datta, G., Davila-Velderrain, J., McGuire, D., Tian, C., et al. (2019). Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet. 51: 237–244, https://doi.org/10.1038/s41588-018-0307-5.Search in Google Scholar PubMed PubMed Central

Liu, Q.R., Walther, D., Drgon, T., Polesskaya, O., Lesnick, T.G., Strain, K.J., de Andrade, M., Bower, J.H., Maraganore, D.M., and Uhl, G.R. (2005). Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B: 93–103, https://doi.org/10.1002/ajmg.b.30109.Search in Google Scholar PubMed

Lodhi, R.J., Wang, Y., Macintyre, G., Crocker, C., Loverock, A., Henriques, B.C., Heywood, B., Sivapalan, S., Bowker, A., Majeau, B., et al. (2019). Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis. Psychiatry Res. 280: 112500, https://doi.org/10.1016/j.psychres.2019.112500.Search in Google Scholar PubMed

Lopez-Leon, S., González-Giraldo, Y., Wegman-Ostrosky, T., and Forero, D.A. (2021). Molecular genetics of substance use disorders: an umbrella review. Neurosci. Biobehav. Rev. 124: 358–369, https://doi.org/10.1016/j.neubiorev.2021.01.019.Search in Google Scholar PubMed

Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D.I., and Yucel, M. (2014). The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature. Curr. Pharm. Des. 20: 2138–2167, https://doi.org/10.2174/13816128113199990435.Search in Google Scholar PubMed

Mancusi, G., Miuli, A., Santorelli, M., Cavallotto, C., Susini, O., Pernaci, G., Výborová, E., Rosa, I., d’Onofrio, A.M., Camardese, G., et al. (2024). Exploring peripheral biomarkers in psychostimulant use: a systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors. Behav. Brain Res. 469: 115046, https://doi.org/10.1016/j.bbr.2024.115046.Search in Google Scholar PubMed

Mané, A., Bergé, D., Penzol, M.J., Parellada, M., Bioque, M., Lobo, A., González-Pinto, A., Corripio, I., Cabrera, B., Sánchez-Torres, A.M., et al. (2017). Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Res. 250: 38–43, https://doi.org/10.1016/j.psychres.2017.01.045.Search in Google Scholar PubMed

Matsushita, S., Kimura, M., Miyakawa, T., Yoshino, A., Murayama, M., Masaki, T., and Higuchi, S. (2004). Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin. Exp. Res. 28: 1609–1612, https://doi.org/10.1097/01.alc.0000145697.81741.d2.Search in Google Scholar PubMed

Meng, C., Lan, J., Wang, Y., Song, M., Gao, X., Ran, L., Moira, S., and Wang, W. (2012). Influence of brain-derived neurotrophic factor genetic polymorphisms on the ages of onset for heroin dependence in a Chinese population. Genet. Test. Mol. Biomarkers 16: 1044–1050, https://doi.org/10.1089/gtmb.2012.0016.Search in Google Scholar PubMed

Miller, A.P., Bogdan, R., Agrawal, A., and Hatoum, A.S. (2024). Generalized genetic liability to substance use disorders. J. Clin. Invest. 134: e172881, https://doi.org/10.1172/jci172881.Search in Google Scholar PubMed PubMed Central

Mo, M., Fu, X.Y., Zhang, X.L., Zhang, S.C., Zhang, H.Q., Wu, L., Li, J.L., and Zhou, L. (2021). Association of plasma pro-brain-derived neurotrophic factor (proBDNF)/Mature brain-derived neurotrophic factor (mBDNF) levels with BDNF gene Val66Met polymorphism in alcohol dependence. Med. Sci. Monit. 27: e930421, https://doi.org/10.12659/msm.930421.Search in Google Scholar

Mon, A., Durazzo, T.C., Gazdzinski, S., Hutchison, K.E., Pennington, D., and Meyerhoff, D.J. (2013). Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Gene Brain Behav. 12: 98–107, https://doi.org/10.1111/j.1601-183x.2012.00854.x.Search in Google Scholar

Montag, C., Basten, U., Stelzel, C., Fiebach, C.J., and Reuter, M. (2008). The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 442: 30–33, https://doi.org/10.1016/j.neulet.2008.06.064.Search in Google Scholar PubMed

Morelos-Santana, E., Islas-Preciado, D., Alcalá-Lozano, R., González-Olvera, J., and Estrada-Camarena, E. (2024). Peripheral neurotrophin levels during controlled crack/cocaine abstinence: a systematic review and meta-analysis. Sci. Rep. 14: 1410, https://doi.org/10.1038/s41598-024-51901-2.Search in Google Scholar PubMed PubMed Central

Muschler, M.A., Heberlein, A., Frieling, H., Vogel, N., Becker, C.M., Kornhuber, J., Bleich, S., and Hillemacher, T. (2011). Brain-derived neurotrophic factor, Val66Met single nucleotide polymorphism is not associated with alcohol dependence. Psychiatr. Genet. 21: 53–54, https://doi.org/10.1097/ypg.0b013e32834133ab.Search in Google Scholar

Nedic, G., Perkovic, M.N., Sviglin, K.N., Muck-Seler, D., Borovecki, F., and Pivac, N. (2013). Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes. Prog. Neuropsychopharmacol. Biol. Psychiatry 40: 193–198, https://doi.org/10.1016/j.pnpbp.2012.09.005.Search in Google Scholar PubMed

Neves, F.S., Malloy-Diniz, L., Romano-Silva, M.A., Campos, S.B., Miranda, D.M., De Marco, L., Figueira, P.G., Krebs, M.O., and Correa, H. (2011). The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J. Affect. Disord. 131: 307–311, https://doi.org/10.1016/j.jad.2010.11.022.Search in Google Scholar PubMed

Nguyen, V.T., Hill, B., Sims, N., Heck, A., Negron, M., Lusk, C., and Galindo, C.L. (2023). Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology. Neural Regen. Res. 18: 102–106, https://doi.org/10.4103/1673-5374.343894.Search in Google Scholar PubMed PubMed Central

Nubukpo, P., Ramoz, N., Girard, M., Malauzat, D., and Gorwood, P. (2017). Determinants of blood brain-derived neurotrophic factor blood levels in patients with alcohol use disorder. Alcohol Clin. Exp. Res. 41: 1280–1287, https://doi.org/10.1111/acer.13414.Search in Google Scholar PubMed

Ohmoto, M. and Takahashi, T. (2019). Effect of genetic polymorphism of brain-derived neurotrophic factor and serotonin transporter on smoking phenotypes: a pilot study of Japanese participants. Heliyon 5: e01234, https://doi.org/10.1016/j.heliyon.2019.e01234.Search in Google Scholar PubMed PubMed Central

Ornell, F., Hansen, F., Schuch, F.B., Pezzini Rebelatto, F., Tavares, A.L., Scherer, J.N., Valerio, A.G., Pechansky, F., Paim Kessler, F.H., and von, Diemen L. (2018). Brain-derived neurotrophic factor in substance use disorders: a systematic review and meta-analysis. Drug Alcohol Depend 193: 91–103, https://doi.org/10.1016/j.drugalcdep.2018.08.036.Search in Google Scholar PubMed

Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., Brennan, S.E., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372: n71, https://doi.org/10.1136/bmj.n71.Search in Google Scholar PubMed PubMed Central

Palma-Álvarez, R.F., Ros-Cucurull, E., Amaro-Hosey, K., Rodriguez-Cintas, L., Grau-López, L., Corominas-Roso, M., Sánchez-Mora, C., and Roncero, C. (2017). Peripheral levels of BDNF and opiate-use disorder: literature review and update. Rev. Neurosci. 28: 499–508, https://doi.org/10.1515/revneuro-2016-0078.Search in Google Scholar PubMed

Panday, S.K., Shankar, V., Lyman, R.A., and Alexov, E. (2024). Genetic variants linked to opioid addiction: a genome-wide association study. Int. J. Mol. Sci. 25: 12516, https://doi.org/10.3390/ijms252312516.Search in Google Scholar PubMed PubMed Central

Peng, Q., Wilhelmsen, K.C., and Ehlers, C.L. (2021). Common genetic substrates of alcohol and substance use disorder severity revealed by pleiotropy detection against GWAS catalog in two populations. Addict. Biol. 26: e12877, https://doi.org/10.1111/adb.12877.Search in Google Scholar PubMed PubMed Central

Peregud, D.I., Baronets, V.Y., Terebilina, N.N., and Gulyaeva, N.V. (2023). Role of BDNF in neuroplasticity associated with alcohol dependence. Biochemistry (Mosc) 88: 404–416, https://doi.org/10.31857/s0320972523030090.Search in Google Scholar

Peregud, D., Korolkov, A., Baronets, V., Kozlov, K., Lobacheva, A., Arkus, M., Bairamova, S., Solovieva, M., Pavlova, O., Pavlov, K., et al. (2024). Genetic determinants of serum brain-derived neurotrophic factor (BDNF) after alcohol withdrawal. Discov. Med. 1: 148, https://doi.org/10.1007/s44337-024-00144-1.Search in Google Scholar

Pezawas, L., Verchinski, B.A., Mattay, V.S., Callicott, J.H., Kolachana, B.S., Straub, R.E., Egan, M.F., Meyer-Lindenberg, A., and Weinberger, D.R. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 24: 10099–10102, https://doi.org/10.1523/jneurosci.2680-04.2004.Search in Google Scholar

Rovaris, D.L., Schuch, J.B., Grassi-Oliveira, R., Sanvicente-Vieira, B., da Silva, B.S., Walss-Bass, C., Müller, D., Stolf, A.R., von Diemen, L., Ceresér, K.M.M., et al. (2017). Effects of crack cocaine addiction and stress-related genes on peripheral BDNF levels. J. Psychiatr. Res. 90: 78–85, https://doi.org/10.1016/j.jpsychires.2017.02.011.Search in Google Scholar PubMed

Roviš, D., Černelič Bizjak, M., Vasiljev Marchesi, V., Petelin, A., Jenuš, T., Vidic, S., Drevenšek, G., and Jenko Pražnikar, Z. (2018). Increased risk-taking behaviour and brain-derived neurotrophic factor Val66Met polymorphism correlates to decreased serum brain-derived neurotrophic factor level in heroin users. Eur. Addict. Res. 24: 189–200, https://doi.org/10.1159/000492582.Search in Google Scholar PubMed

Roy, N., Barry, R.J., Fernandez, F.E., Lim, C.K., Al-Dabbas, M.A., Karamacoska, D., Broyd, S.J., Solowij, N., Chiu, C.L., and Steiner, G.Z. (2020). Electrophysiological correlates of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism. Sci. Rep. 10: 17915, https://doi.org/10.1038/s41598-020-74780-9.Search in Google Scholar PubMed PubMed Central

Russo, S.J., Mazei-Robison, M.S., Ables, J.L., and Nestler, E.J. (2009). Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56: 73–82, https://doi.org/10.1016/j.neuropharm.2008.06.059.Search in Google Scholar PubMed PubMed Central

Saha, S., Lim, C.C., Degenhardt, L., Cannon, D.L., Bremner, M., Prentis, F., Lawrence, Z., Heffernan, E., Meurk, C., Reilly, J., et al. (2022). Comorbidity between mood and substance-related disorders: a systematic review and meta-analysis. Aust. N. Z. J. Psychiatry 56: 757–770, https://doi.org/10.1177/00048674211054740.Search in Google Scholar PubMed

Saunders, G.R.B., Wang, X., Chen, F., Jang, S.K., Liu, M., Wang, C., Gao, S., Jiang, Y., Khunsriraksakul, C., Otto, J.M., et al. (2022). Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature 612: 720–724, https://doi.org/10.1038/s41586-022-05477-4.Search in Google Scholar PubMed PubMed Central

Serý, O., Sťastný, F., Zvolský, P., Hlinomazová, Z., and Balcar, V.J. (2011). Association between Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) gene and a deficiency of colour vision in alcohol-dependent male patients. Neurosci. Lett. 499: 154–157, https://doi.org/10.1016/j.neulet.2011.05.038.Search in Google Scholar PubMed

Shafiee, A., Jafarabady, K., Rafiei, M.A., Beiky, M., Seighali, N., Golpayegani, G., Jalali, M., Soltani Abhari, F., Arabzadeh Bahri, R., Safari, O., et al. (2023). Effect of alcohol on brain-derived neurotrophic factor (BDNF) blood levels: a systematic review and meta-analysis. Sci. Rep. 13: 17554, https://doi.org/10.1038/s41598-023-44798-w.Search in Google Scholar PubMed PubMed Central

Shafiee, A., Rafiei, M.A., Jafarabady, K., Eskandari, A., Abhari, F.S., Sattari, M.A., Amini, M.J., and Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): a systematic review and meta-analysis. Brain Behav. 14: e3340, https://doi.org/10.1002/brb3.3340.Search in Google Scholar PubMed PubMed Central

Shin, S., Stewart, R., Ferri, C.P., Kim, J.M., Shin, I.S., Kim, S.W., Yang, S.J., and Yoon, J.S. (2010). An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. Int. J. Geriatr. Psychiatry 25: 441–448, https://doi.org/10.1002/gps.2358.Search in Google Scholar PubMed

Shkundin, A. and Halaris, A. (2023). Associations of BDNF/BDNF-AS SNPs with depression, schizophrenia, and bipolar disorder. J. Pers. Med. 13: 1395, https://doi.org/10.3390/jpm13091395.Search in Google Scholar PubMed PubMed Central

Sim, M.S., Mohamed, Z., Hatim, A., Rajagopal, V.L., and Habil, M.,H. (2010). Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 1357: 91–96, https://doi.org/10.1016/j.brainres.2010.08.053.Search in Google Scholar PubMed

Sohani, Z.N., Meyre, D., de Souza, R.J., Joseph, P.G., Gandhi, M., Dennis, B.B., Norman, G., and Anand, S.S. (2015). Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genet. 16: 50, https://doi.org/10.1186/s12863-015-0211-2.Search in Google Scholar PubMed PubMed Central

Spencer, J.L., Waters, E.M., Milner, T.A., Lee, F.S., and McEwen, B.S. (2010). BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function. Proc. Natl. Acad. Sci. USA. 107: 4395–4400, https://doi.org/10.1073/pnas.0915105107.Search in Google Scholar PubMed PubMed Central

Strońska-Pluta, A., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Boroń, A., Masiak, J., Sipak-Szmigiel, O., Recław, R., and Grzywacz, A. (2024). The relationship between the brain-derived neurotrophic factor gene polymorphism (Val66Met) and substance use disorder and relapse. Int. J. Mol. Sci. 25: 788, https://doi.org/10.3390/ijms25020788.Search in Google Scholar PubMed PubMed Central

Su, H., Tao, J., Zhang, J., Xie, Y., Han, B., Lu, Y., Sun, H., Wei, Y., Wang, Y., Zhang, Y., et al. (2015a). The analysis of BDNF gene polymorphism haplotypes and impulsivity in methamphetamine abusers. Compr. Psychiatry 59: 62–67, https://doi.org/10.1016/j.comppsych.2015.02.017.Search in Google Scholar PubMed

Su, H., Tao, J., Zhang, J., Xie, Y., Sun, Y., Li, L., Xu, K., Han, B., Lu, Y., Sun, H., et al. (2014). An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers. Neurosci. Lett. 582: 16–20, https://doi.org/10.1016/j.neulet.2014.08.030.Search in Google Scholar PubMed

Su, H., Tao, J., Zhang, J., Xie, Y., Wang, Y., Zhang, Y., Han, B., Lu, Y., Sun, H., Wei, Y., et al. (2015b). The effects of BDNF Val66Met gene polymorphism on serum BDNF and cognitive function in methamphetamine-dependent patients and normal controls: a case-control study. J. Clin. Psychopharmacol. 35: 517–524, https://doi.org/10.1097/jcp.0000000000000390.Search in Google Scholar PubMed

Su, N., Zhang, L., Fei, F., Hu, H., Wang, K., Hui, H., Jiang, X.F., Li, X., Zhen, H.N., Li, J., et al. (2011). The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response. Brain Res. 1415: 119–126, https://doi.org/10.1016/j.brainres.2011.08.005.Search in Google Scholar PubMed

Tajbakhsh, A., Alimardani, M., Asghari, M., Abedini, S., Saghafi Khadem, S., Nesaei Bajestani, A., Alipoor, F., Alidoust, M., Savardashtaki, A., Hashemian, P., et al. (2021). Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study. BMC Med. Genomics 14: 27, https://doi.org/10.1186/s12920-021-00873-7.Search in Google Scholar PubMed PubMed Central

Toh, Y.L., Ng, T., Tan, M., Tan, A., and Chan, A. (2018). Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: a systematic review. Brain Behav. 8: e01009, https://doi.org/10.1002/brb3.1009.Search in Google Scholar PubMed PubMed Central

Tsai, S.J., Liao, D.L., Yu, Y.W., Chen, T.J., Wu, H.C., Lin, C.H., Cheng, C.Y., and Hong, C.J. (2005). A study of the association of (Val66Met) polymorphism in the brain-derived neurotrophic factor gene with alcohol dependence and extreme violence in Chinese males. Neurosci. Lett. 381: 340–343, https://doi.org/10.1016/j.neulet.2005.02.043.Search in Google Scholar PubMed

Uhl, G.R., Liu, Q.R., Walther, D., Hess, J., and Naiman, D. (2001). Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am. J. Hum. Genet. 69: 1290–1300, https://doi.org/10.1086/324467.Search in Google Scholar PubMed PubMed Central

Wall, T.L., Luczak, S.E., and Hiller-Sturmhöfel, S. (2016). Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 38: 59–68.10.35946/arcr.v38.1.08Search in Google Scholar

Walters, R.K., Polimanti, R., Johnson, E.C., McClintick, J.N., Adams, M.J., Adkins, A.E., Aliev, F., Bacanu, S.A., Batzler, A., Bertelsen, S., et al. (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat. Neurosci. 21: 1656–1669, https://doi.org/10.1038/s41593-018-0275-1.Search in Google Scholar PubMed PubMed Central

Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., and Xu, J. (2023). Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis. Front. Psychiatry 14: 1143833, https://doi.org/10.3389/fpsyt.2023.1143833.Search in Google Scholar PubMed PubMed Central

Wang, L., Nuñez, Y.Z., Martínez-Magaña, J.J., Rivera-Hernandez, M., Mao, Z., Brennand, K.J., Montalvo-Ortiz, J.L., Kranzler, H.R., Gelernter, J., and Zhou, H. (2025). Whole-exome sequencing study of opioid dependence offers novel insights into the contributions of exome variants. Transl. Psychiatry 15: 380, https://doi.org/10.1038/s41398-025-03578-y.Search in Google Scholar PubMed PubMed Central

Wei, S.M., Baller, E.B., Kohn, P.D., Kippenhan, J.S., Kolachana, B., Soldin, S.J., Rubinow, D.R., Schmidt, P.J., and Berman, K.F. (2018). Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study. Mol. Psychiatr. 23: 1066–1075, https://doi.org/10.1038/mp.2017.72.Search in Google Scholar PubMed PubMed Central

Wei, S.M. and Berman, K.F. (2019). Ovarian hormones, genes, and the brain: the case of estradiol and the brain-derived neurotrophic factor (BDNF) gene. Neuropsychopharmacology 44: 223–224, https://doi.org/10.1038/s41386-018-0223-5.Search in Google Scholar PubMed PubMed Central

Wojnar, M., Brower, K.J., Strobbe, S., Ilgen, M., Matsumoto, H., Nowosad, I., Sliwerska, E., and Burmeister, M. (2009). Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin. Exp. Res. 33: 693–702, https://doi.org/10.1111/j.1530-0277.2008.00886.x.Search in Google Scholar PubMed PubMed Central

Wootton, R.E., Richmond, R.C., Stuijfzand, B.G., Lawn, R.B., Sallis, H.M., Taylor, G.M.J., Hemani, G., Jones, H.J., Zammit, S., Davey Smith, G., et al. (2020). Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol. Med. 50: 2435–2443, https://doi.org/10.1017/s0033291719002678.Search in Google Scholar

Xu, H., Toikumo, S., Crist, R.C., Glogowska, K., Jinwala, Z., Deak, J.D., Justice, A.C., Gelernter, J., Johnson, E.C., Kranzler, H.R., et al. (2023). Identifying genetic loci and phenomic associations of substance use traits: a multi-trait analysis of GWAS (MTAG) study. Addiction 118: 1942–1952, https://doi.org/10.1111/add.16229.Search in Google Scholar PubMed PubMed Central

Yang, S., Wang, F., Sun, L., Liu, X., Li, S., Chen, Y., Chen, L., Pan, Z., Kang, Y., Chen, Y.H., et al. (2024). The effects of BDNF rs6265 and FGF21 rs11665896 polymorphisms on alcohol use disorder-related impulsivity in Han Chinese adults. Front. Psychiatry 15: 1339558, https://doi.org/10.3389/fpsyt.2024.1339558.Search in Google Scholar PubMed PubMed Central

Zai, C.C., Manchia, M., Zai, G.C., Woo, J., Tiwari, A.K., de Luca, V., and Kennedy, J.L. (2018). Association study of BDNF and DRD3 genes with alcohol use disorder in schizophrenia. Neurosci. Lett. 671: 1–6, https://doi.org/10.1016/j.neulet.2018.01.033.Search in Google Scholar PubMed

Zhang, X.Y., Chen, D.C., Tan, Y.L., Luo, X., Zuo, L., Lv, M.H., Shah, N.N., Zunta-Soares, G.B., and Soares, J.C. (2015). Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study. J. Psychiatr. Res. 60: 49–55, https://doi.org/10.1016/j.jpsychires.2014.09.023.Search in Google Scholar PubMed

Zhang, X.Y., Chen, D.C., Xiu, M.H., Luo, X., Zuo, L., Haile, C.N., Kosten, T.A., and Kosten, T.R. (2012). BDNF Val66Met variant and smoking in a Chinese population. PLoS One 7: e53295, https://doi.org/10.1371/journal.pone.0053295.Search in Google Scholar PubMed PubMed Central

Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H.R., van Dyck, C.H., Charney, D.S., Price, L.H., Southwick, S., Yang, B.Z., Rasmussen, A., et al. (2006). Brain derived neurotrophic factor (BDNF) gene variants and alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B: 387–393, https://doi.org/10.1002/ajmg.b.30332.Search in Google Scholar PubMed PubMed Central

Zhou, H., Kember, R.L., Deak, J.D., Xu, H., Toikumo, S., Yuan, K., Lind, P.A., Farajzadeh, L., Wang, L., Hatoum, A.S., et al. (2023). Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. Nat. Med. 29: 3184–3192, https://doi.org/10.1038/s41591-023-02653-5.Search in Google Scholar PubMed PubMed Central

Zhou, H., Sealock, J.M., Sanchez-Roige, S., Clarke, T.K., Levey, D.F., Cheng, Z., Li, B., Polimanti, R., Kember, R.L., Smith, R.V., et al. (2020). Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat. Neurosci. 23: 809–818, https://doi.org/10.1038/s41593-020-0643-5.Search in Google Scholar PubMed PubMed Central